These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 39108120)

  • 21. MCR: modern colistin resistance.
    Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia.
    Memish ZA; Shibl AM; Kambal AM; Ohaly YA; Ishaq A; Livermore DM
    J Antimicrob Chemother; 2012 Jul; 67(7):1701-5. PubMed ID: 22461312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 25. Colistin in the 21st century.
    Nation RL; Li J
    Curr Opin Infect Dis; 2009 Dec; 22(6):535-43. PubMed ID: 19797945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infections.
    Wang Y; Yu L; Zhu J; Liang G; Liu J; Zheng Y; Zhao Y; Yu Z
    Sci Rep; 2024 Oct; 14(1):23635. PubMed ID: 39384871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. A retrospective study at a tertiary care hospital in Southwest Saudi Arabia.
    Ibrahim ME
    Saudi Med J; 2018 Oct; 39(10):1035-1043. PubMed ID: 30284588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin: an antibiotic and its role in multiresistant Gram-negative infections.
    Loho T; Dharmayanti A
    Acta Med Indones; 2015 Apr; 47(2):157-68. PubMed ID: 26260559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of multidrug resistance in prevalent Gram-negative bacteria in burn patients in Iran: A systematic review and meta-analysis.
    Javanmardi F; Emami A; Pirbonyeh N; Rajaee M; Hatam G; Keshavarzi A
    J Glob Antimicrob Resist; 2019 Dec; 19():64-72. PubMed ID: 31063845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME; Kasiakou SK
    Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India.
    Irusan D; Akshay SD; Shetty VP; Karunasagar I; Deekshit VK; Rohit A
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38986507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
    Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
    Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria.
    Huang Y; Zhu Y; Yue H-Y; Liu Y-Y; Deng L-M; Lv L; Wang C; Yang J; Liu J-H
    mSystems; 2024 Jun; 9(6):e0010924. PubMed ID: 38695565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
    Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
    Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.